BML, Inc. 4694.T Stock

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services. In addition, the company offers food sanitation test, including food sanitation control and food processing services, which comprise contract services for microorganism testing of raw materials, and prepared and processed food; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and wastewater tests; work environment services, such as measurement of ethylene oxide gas, formaldehyde, organic solvent, and dust; environmental monitoring, which include measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; gene expression analysis and testing for genes that cause susceptibility to infectious diseases; and human genome analysis services. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.